UY29382A1 - Agentes frmacéuticos que contienen complejos metalicos con contenido de fluoroalquilo y epotilonas. - Google Patents

Agentes frmacéuticos que contienen complejos metalicos con contenido de fluoroalquilo y epotilonas.

Info

Publication number
UY29382A1
UY29382A1 UY29382A UY29382A UY29382A1 UY 29382 A1 UY29382 A1 UY 29382A1 UY 29382 A UY29382 A UY 29382A UY 29382 A UY29382 A UY 29382A UY 29382 A1 UY29382 A1 UY 29382A1
Authority
UY
Uruguay
Prior art keywords
fluoroalkyl
agents containing
frmaceutical
epotilone
contents
Prior art date
Application number
UY29382A
Other languages
English (en)
Inventor
Ulrich Klar
Jens Hoffmann
Johannes Platzek
Heiko Schirmer
Rudiger Lawaczeck
Wolf-Ruediger Press
Katja Schoen
Bernd Misselwitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29382A1 publication Critical patent/UY29382A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Abstract

La invención se refiere a agentes farmacéuticos que contienen al menos un complejo metálico con contenidode fluoroalquilo, que presenta una concentración crítica de formación de micelas -10-3 mol/1 y un diámetro hidrodinámico de micelas (2Rh) - 1 nm y al menos una epotilana o derivado de epotilona naturales o sintéticos, eventualmente con los aditivos usuales en la galénica.
UY29382A 2005-02-17 2006-02-16 Agentes frmacéuticos que contienen complejos metalicos con contenido de fluoroalquilo y epotilonas. UY29382A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008309A DE102005008309A1 (de) 2005-02-17 2005-02-17 Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone

Publications (1)

Publication Number Publication Date
UY29382A1 true UY29382A1 (es) 2006-10-02

Family

ID=36123179

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29382A UY29382A1 (es) 2005-02-17 2006-02-16 Agentes frmacéuticos que contienen complejos metalicos con contenido de fluoroalquilo y epotilonas.

Country Status (12)

Country Link
US (1) US20060257322A1 (es)
EP (1) EP1848429A1 (es)
JP (1) JP2008530157A (es)
AR (1) AR052912A1 (es)
DE (1) DE102005008309A1 (es)
DO (1) DOP2006000038A (es)
GT (1) GT200600073A (es)
PA (1) PA8663801A1 (es)
PE (1) PE20061064A1 (es)
TW (1) TW200640456A (es)
UY (1) UY29382A1 (es)
WO (1) WO2006087145A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
FR2775187B1 (fr) * 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
EP1475105A1 (en) * 2003-05-09 2004-11-10 Schering AG Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy

Also Published As

Publication number Publication date
PE20061064A1 (es) 2006-11-08
TW200640456A (en) 2006-12-01
PA8663801A1 (es) 2006-12-07
AR052912A1 (es) 2007-04-11
US20060257322A1 (en) 2006-11-16
DE102005008309A1 (de) 2006-08-24
WO2006087145A1 (de) 2006-08-24
EP1848429A1 (de) 2007-10-31
JP2008530157A (ja) 2008-08-07
GT200600073A (es) 2007-01-03
DOP2006000038A (es) 2006-08-15

Similar Documents

Publication Publication Date Title
PE20070420A1 (es) Formulacion que contiene una combinacion de valsartan y amlodipina
AR050946A1 (es) Composiciones para el tratamiento de la ropa.
ATE524570T1 (de) Metallfolie
CL2007003447A1 (es) Composicion lubricante que comprende un aceite base, fosfato tricalcico en concentraciones de 2 a 68% en peso relativo a la composicion total y un agente tensioactivo; y uso de dicah composicion.
AR039309A1 (es) Composicion cosmetica multifasica
PL1957041T3 (pl) Emulsja olej-w-wodzie i jej zastosowanie dla nadania funkcji
NO20016309D0 (no) Flersjiktskompositt på polyamid/polyolefin-basis
IN2014DN09063A (es)
CO5720212A1 (es) Composicion de anticuerpo her2
AR029733A1 (es) Composicion principalmente cosmetica o farmaceutica que se presenta en forma solida
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
FR2926218B1 (fr) Composition comprenant un retinoide et du peroxyde de benzoyle disperse.
UY29382A1 (es) Agentes frmacéuticos que contienen complejos metalicos con contenido de fluoroalquilo y epotilonas.
ITRM20050209A1 (it) Composizione a base di olio d'oliva arricchita e supplementata con luteina.
AR072333A1 (es) Composiciones inyectables a base de taxoides
WO2007070523A3 (en) Personal care compositions comprising ppar. gamma. antagonists
DE60006621D1 (de) Mischungen für Barriereschichten für Nahrungsmittel
BR0112537A (pt) Preparações cosméticas de embelezamento contendo dialquilcarbonatos e óxidos de metal
AR063852A1 (es) Composicion cosmetica
DE60305455D1 (de) Mit doppelten schultern ausgestattene verbindung für ölfeldrohre
TH84986B (th) สารเภสัชวิทยาที่มีสารเชิงซ้อนโลหะที่มีฟลูออโรแอลคิล และอีโพไธโลน
TH84986A (th) สารเภสัชวิทยาที่มีสารเชิงซ้อนโลหะที่มีฟลูออโรแอลคิล และอีโพไธโลน
ATE401257T1 (de) Einzeldosisverpackung
권승 The Analysis of Organizational Characteristics Leading to the Adoption of Voluntary Family-Friendly Benefits in the Workplace
FR3070160B1 (fr) Piece instrumentalisable pour contenant

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160805